Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

C4B antibody

This Mouse Monoclonal antibody specifically detects C4B in IF and IHC (f). It exhibits reactivity toward Human.
Catalog No. ABIN6936545

Quick Overview for C4B antibody (ABIN6936545)

Target

See all C4B (C4b) Antibodies
C4B (C4b) (Complement Component C4b (C4b))

Reactivity

  • 54
  • 23
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Host

  • 63
  • 9
  • 3
Mouse

Clonality

  • 66
  • 9
Monoclonal

Conjugate

  • 32
  • 9
  • 8
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This C4B antibody is un-conjugated

Application

  • 42
  • 30
  • 20
  • 18
  • 13
  • 13
  • 12
  • 7
  • 6
  • 5
  • 3
  • 3
  • 2
  • 2
  • 1
Immunofluorescence (IF), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))

Clone

SPM545
  • Specificity

    This MAb is specific to Complement 4d (C4d) and it reacts with the secreted as well as cell-bound C4d.C4d is a degradation product of the activated complement factor C4b. Complement 4b is typically activated by binding of Abs to specific target molecules. Following activation and degradation of the C4 Molecule, thio-ester groups are exposed, which allow transient, covalent binding of the degradation product Complement 4d to endothelial cell surfaces and extracellular matrix components of vascular basement membranes near the sites of C4 activation. The presence of C4d in peritubular capillaries is a key indicator for acute humoral (i.e. antibody-mediated) rejection of kidney, heart, pancreas and lung allografts. As an established marker of antibody-mediated acute renal allograft rejection and its proclivity for endothelium, this component can be detected in peritubular capillaries in chronic renal allograft rejection as well as hyperacute rejection, acute vascular rejection, acute cellular rejection, and borderline rejection. It has been shown to be a significant predictor of transplant kidney graft survival. Anti-C4d, combined with anti-C3d, can be utilized as a tool for diagnosis of allograft rejection that may warrant a prompt and aggressive anti-rejection treatment.

    Cross-Reactivity (Details)

    Human.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Recombinant human Complement 4d protein

    Isotype

    IgG1 kappa
  • Application Notes

    Known_Application: Immunofluorescence (1:50-1:100), Immunohistochemistry (Formalin-fixed) (1:200-1:400 for 30 minutes at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 1 mM EDTA, pH 7.5-8.5, for 45 min at 95°C followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined.

    Positive_Control: Rejected Renal Transplant Tissue.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Preservative

    Azide free

    Storage

    -20 °C,-80 °C

    Storage Comment

    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Expiry Date

    24 months
  • Target

    C4B (C4b) (Complement Component C4b (C4b))

    Alternative Name

    C4B

    Background

    Acidic Complement C4, Basic C4, C4, C4-1, C4a Anaphylatoxin, C4A, C4A2, C4A3, C4A4, C4A6, C4b, C4B1, C4B12, C4d fragment, C4F, C4S, Complement C4 Gamma Chain, Complement Component 4A, Complement Component 4B,Complement 4d (C4d) (Acute Humoral Rejection Marker)
    Cellular localisation: Intracytoplasmic vacuoles of endothelial cells and Secreted

    Molecular Weight

    192kDa (predicted)

    Gene ID

    720, 721, 534847

    Pathways

    Complement System
You are here:
Chat with us!